Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1996-05-22 (29 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE CRES (34920), Herault
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
LA PHARMACIE DU CRES : revenue, balance sheet and financial ratios
LA PHARMACIE DU CRES is a French company
founded 29 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE CRES (34920),
this company of category PME
shows in 2025 a net income positive of 69 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LA PHARMACIE DU CRES (SIREN 405350810)
Indicator
2025
Revenue
N/C
Net income
69 336 €
EBITDA
N/C
Net margin
N/C
Revenue and income statement
In 2025, LA PHARMACIE DU CRES generates positive net income of 69 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
69 336 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
22.338%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.279%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution LA PHARMACIE DU CRES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2025
Debt ratio
22.338
Financial autonomy
63.279
Repayment capacity
None
Cash flow / Revenue
None%
Sector positioning
Debt ratio
22.342025
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of LA PHARMACIE DU CRES (22.34) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
63.28%2025
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good
In 2025, the financial autonomy of LA PHARMACIE DU CRES (63.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 151.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
151.916
Liquidity indicators evolution LA PHARMACIE DU CRES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2025
Liquidity ratio
151.916
Interest coverage
None
Sector positioning
Liquidity ratio
151.922025
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average
In 2025, the liquidity ratio of LA PHARMACIE DU CRES (151.92) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of LA PHARMACIE DU CRES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of LA PHARMACIE DU CRES is estimated at
1 101 410 €
(range 747 422€ - 1 728 264€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
747k€1101k€1728k€
1 101 410 €Range: 747 422€ - 1 728 264€
NAF 5 année 2025
Valuation method used
Net Income Multiple
69 336 €
×
15.9x
=1 101 411 €
Range: 747 422€ - 1 728 265€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare LA PHARMACIE DU CRES with other companies in the same sector:
Frequently asked questions about LA PHARMACIE DU CRES
What is the revenue of LA PHARMACIE DU CRES ?
The revenue of LA PHARMACIE DU CRES is not publicly disclosed (confidential accounts filed with INPI).
Is LA PHARMACIE DU CRES profitable?
Yes, LA PHARMACIE DU CRES generated a net profit of 69 k€ in 2025.
Where is the headquarters of LA PHARMACIE DU CRES ?
The headquarters of LA PHARMACIE DU CRES is located in LE CRES (34920), in the department Herault.
Where to find the tax return of LA PHARMACIE DU CRES ?
The tax return of LA PHARMACIE DU CRES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LA PHARMACIE DU CRES operate?
LA PHARMACIE DU CRES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart